Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

Massachusetts General Hospital · NCT05881239

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–100 · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
250
US sites recruiting
1
Study start
May 9, 2023
Record last updated
March 6, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this study is to objectively test one's sense of smell, called olfaction, in participants with Subjective Cognitive Concerns (SCC), Mild Cognitive Impairment, Mild Behavioral Impairment (MBI), and age-matched controls. The main question it aims to answer is whether the AROMHA Brain Health Test could serve as a predictive biomarker of neurodegenerative disorders. This understanding will aid in the development of a noninvasive, cost-effective diagnostic tool that reliably and specifically distinguishes disease and normal aging populations.

Participants will take the approximately 45-minute AROMHA Brain Health Smell Test where they will peel and sniff labels on the physical smell cards and answer questions on the web-based app relating to what they smelled. Participants will undergo tests for odor intensity, odor identification, odor discrimination, and episodic olfactory memory, but will not be provided the results of these tests.

Being studied: AROMHA Brain Health Test

Conditions: Subjective Cognitive Concerns; Mild Cognitive Impairment; Mild Behavioral Impairment; Healthy Aging

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • A clinical or research consensus diagnosis of the patient's condition or control status.
  • Individuals that are at least 18 years of age at the time of enrollment.
  • Individuals that are no older than 100 years of age at the time of enrollment.

Exclusion Criteria

  • Primary pulmonary disease such as severe emphysema or asthma not under good medical control.
  • Current sinusitis, common cold, upper respiratory infection, or nasal polyps.
  • Current or recent (past 6 months) alcohol or substance dependence. A prior history of alcohol or substance abuse will not be grounds for exclusion.
  • Pregnancy.
  • Severe cognitive dysfunction that would preclude completion of the olfactory testing.
  • An adverse reaction to fragrances (ie. they trigger a severe asthmatic attack or nausea).

Recruiting US locations

  • Massachusetts General Hospital

    Boston, MA 02129

    Site contact: Mark W Albers, MD PhD · 617-724-7401 · albers.mark@mgh.harvard.edu

Study contacts (from the official record)

  • Mark W Albers, MD PhD · 617-724-7401 · albers.mark@mgh.harvard.edu
  • Alefiya Albers, PhD · AALBERS@mgh.harvard.edu
All neurology studies in Massachusetts →
Digital Accessible Remote Olfactory Mediated Health Assessments… (NCT05881239) | Bored Studies